Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3769776018 | Product containing precisely levonorgestrel 833 nanogram/1 hour prolonged-release intrauterine drug delivery system (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3769777010 | Levonorgestrel 833 nanogram/hour prolonged-release intrauterine drug delivery system | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely levonorgestrel 833 nanogram/1 hour prolonged-release intrauterine drug delivery system (clinical drug) | Has concentration strength denominator unit | hour | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely levonorgestrel 833 nanogram/1 hour prolonged-release intrauterine drug delivery system (clinical drug) | Has manufactured dose form | Prolonged-release intrauterine drug delivery system | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely levonorgestrel 833 nanogram/1 hour prolonged-release intrauterine drug delivery system (clinical drug) | Has precise active ingredient | Levonorgestrel | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely levonorgestrel 833 nanogram/1 hour prolonged-release intrauterine drug delivery system (clinical drug) | Plays role | Contraceptive therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely levonorgestrel 833 nanogram/1 hour prolonged-release intrauterine drug delivery system (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely levonorgestrel 833 nanogram/1 hour prolonged-release intrauterine drug delivery system (clinical drug) | Is a | Product containing only levonorgestrel in intrauterine dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely levonorgestrel 833 nanogram/1 hour prolonged-release intrauterine drug delivery system (clinical drug) | Has concentration strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely levonorgestrel 833 nanogram/1 hour prolonged-release intrauterine drug delivery system (clinical drug) | Has concentration strength numerator unit | nanogram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely levonorgestrel 833 nanogram/1 hour prolonged-release intrauterine drug delivery system (clinical drug) | Has concentration strength numerator value | 833 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely levonorgestrel 833 nanogram/1 hour prolonged-release intrauterine drug delivery system (clinical drug) | Has basis of strength substance | Levonorgestrel | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely levonorgestrel 833 nanogram/1 hour prolonged-release intrauterine drug delivery system (clinical drug) | Has manufactured dose form | Prolonged-release intrauterine delivery system | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR